about
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP poolInhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosisMembrane-Depolarizing Channel Blockers Induce Selective Glioma Cell Death by Impairing Nutrient Transport and Unfolded Protein/Amino Acid Responses.Design of a general-purpose European compound screening library for EU-OPENSCREEN.dUTPase inhibition augments replication defects of 5-Fluorouracil.Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation.A Drosophila female pheromone elicits species-specific long-range attraction via an olfactory channel with dual specificity for sex and food.Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.Design of a highly selective and potent class of non-planar estrogen receptor β agonists.High-affinity recognition of the human C-reactive protein independent of phosphocholine.A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.Identification of inhibitors of Tartrate-resistant acid phosphatase (TRAP/ACP5) activity by small-molecule screening.Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.The A-CD analogue of 16β,17α-estriol is a potent and highly selective estrogen receptor β agonistExploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
P50
Q27643976-54233137-6836-4599-B4E9-BE08F74D80DAQ27716525-F4CE5224-9992-43FF-A318-586A491EC335Q38721366-21081A6D-FB36-4D6E-B8C1-7B66021F505DQ39156659-74411BD3-1594-4C64-A999-4A5F3B83DFCBQ41767730-6A4B3255-8695-4DEC-B0B0-50ABC064CE79Q42221409-C86CC963-ACA7-44A7-887D-4076301E5594Q42287236-4F112B0C-5918-4258-A235-4CD0837F5CE7Q46929150-06B6BAC2-CE0D-4CA1-8CDE-FAEC0F065D1CQ47252031-A7EE75DD-029F-4E39-874A-6FF42F077B29Q48223029-D6033A44-8702-47D2-943B-04D14F0B3015Q50893106-2167FD07-CA68-46C5-A414-EB544DFA515AQ50996823-11E5C057-9601-4A2D-B44B-440DD2EEDC57Q52352234-3C2C091A-67BD-4E0B-BAE9-5A072DAFB436Q52729152-3925B12E-0272-46A1-BD81-01C144692842Q55270235-65EC2570-C0CF-468C-8E23-74FBBD467158Q64028278-74C19C44-C500-45ED-9746-CBACBA94ADD0Q90245486-D2DBE141-A475-4F74-B7A3-F205936D9499
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna-Lena Gustavsson
@ast
Anna-Lena Gustavsson
@en
Anna-Lena Gustavsson
@es
Anna-Lena Gustavsson
@nl
type
label
Anna-Lena Gustavsson
@ast
Anna-Lena Gustavsson
@en
Anna-Lena Gustavsson
@es
Anna-Lena Gustavsson
@nl
prefLabel
Anna-Lena Gustavsson
@ast
Anna-Lena Gustavsson
@en
Anna-Lena Gustavsson
@es
Anna-Lena Gustavsson
@nl
P106
P31
P496
0000-0003-4332-2336